Stable expression of small interfering RNA sensitizes TEL-PDGFβR to inhibition with imatinib or rapamycin

Small molecule inhibitors, such as imatinib, are effective therapies for tyrosine kinase fusions BCR-ABL–TEL-PDGFβR–mediated human leukemias, but resistance may develop. The unique fusion junctions of these molecules are attractive candidates for molecularly targeted therapeutic intervention using R...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Chen, Jing, Wall, Nathan R., Kocher, Kerry, Duclos, Nicole, Fabbro, Doriano, Neuberg, Donna, Griffin, James D., Shi, Yang, Gilliland, D. Gary
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 2004
Assuntos:	Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC420507/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15199413/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI20673
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!